Please wait a minute...
Frontiers of Medicine

ISSN 2095-0217

ISSN 2095-0225(Online)

CN 11-5983/R

Postal Subscription Code 80-967

2018 Impact Factor: 1.847

Front. Med.    2009, Vol. 3 Issue (3) : 336-340     DOI: 10.1007/s11684-009-0053-2
Research articles |
Effect of lanthanum chloride on growth of breast cancer cells and regulation of transcription
Xue LI MM , Ping HE MM , Jie XIA MM , Shiwei SONG BS , Jinhai LU BM , Yunde LIU MM ,
Department of Clinical Laboratory Sciences, Tianjin Medical University, Tianjin 300203, China;
Download: PDF(113 KB)  
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks
Abstract  Lanthanum salt is a prescription drug, but its underlying functions and mechanisms are not fully understood currently. To explore the potential therapeutic value of lanthanum chloride, cytotoxicity test was applied to investigate its effects on cell proliferation. Furthermore, we observed its influence on pro-oncogene c-met by reverse transcription polymerase chain reaction (RT-PCR). In MCF-7 cell line, lanthanum chloride repressed cell proliferation at high concentration but had no significant inhibition effect on cell growth at low concentration. However, we observed that lanthanum chloride repressed c-met transcription at a low concentration. This may suggest that lanthanum chloride is a potent drug to inhibit the high expression of c-met in carcinoma cells and play a clue for inhibiting the growth and invasion of tumor.
Keywords proliferation      c-met      invasion      lanthanum chloride      
Issue Date: 05 September 2009
URL:  
http://academic.hep.com.cn/fmd/EN/10.1007/s11684-009-0053-2     OR     http://academic.hep.com.cn/fmd/EN/Y2009/V3/I3/336
Hirano S, Suzuki K T. Exposure, metabolism, andtoxicity of rare earths and related compounds. Environ Health Perspect, 1996, 104(Suppl 1): 85―95

doi: 10.2307/3432699
Shen Q, Zhang J, Wang C. Effect of dietary rare earth elements on growth performanceof poultry. Siliao Gongye, 1991, 12(11): 21, 22 (in Chinese)
He M L, Ranz D, Rambeck W A. Study on the performance enhancing effect of rare earthelements in growing and fattening pigs. J Anim Physiol Anim Nutr (Berl), 2001, 85(7,8): 263―270
Wang K, Cheng Y, Yang X, Li R. Cell responsesto lanthanides and potential pharmacological actions of lanthanides. Met Ions Biol Syst, 2003, 40: 707―751
Evans C H. Interesting and useful biochemical properties of lanthanidesTrends Biochem Sci, 1983, 8(12): 445―449

doi: 10.1016/0968-0004(83)90032-4
Autissier V, Damment S J P, Henderson R A. Relative in vitro efficacy of the phosphate binders lanthanumcarbonate and sevelamer hydrochloride. J Pharm Sci, 2007, 96(10): 2818―2827

doi: 10.1002/jps.20956
Finn W F. Lanthanum carbonate versus standard therapy for the treatment ofhyperphosphatemia: safety and efficacy in chronic maintenance hemodialysispatients. Clin Nephrol, 2006, 65(3): 191―202
Shi Y, Gou B D, Shi Y L, Zhang T L, Wang K. Lanthanum chloride suppresses hydrogen peroxide-enhanced calcification in rat calcifyingvascular cells. Biometals, 2009, 22(2): 317―327

doi: 10.1007/s10534-008-9168-1
Anghileri L J. Effects of gallium and lanthanum on experimental tumor growth. Eur J Cancer, 1979, 15(12): 1459―1462

doi: 10.1016/0014-2964(79)90024-0
Dai Y, Li J, Li J, Yu L, Dai G, Hu A, Yuan L, Wen Z. Effects of rare earth compounds on growth and apoptosisof leukemic cell lines. In Vitro Cell DevBiol Anim, 2002, 38(7): 373―375

doi: 10.1290/1071-2690(2002)038<0373:EORECO>2.0.CO;2
Li J, Li J, Dai G, Dai Y C, Wen Z. Effects of Lanthanum chloride on growthand apoptosis of K562 leukemia cell lines. Bai Xue Bing·Lin Ba Liu, 2006, 15(6): 405―407 (in Chinese)
Heffeter P, Jakupec M A, Körner W, Chiba P, Pirker C, Dornetshuber R, Elbling L, Sutterlüty H, Micksche M, Keppler B K, Berger W. Multidrug-resistant cancer cells are preferential targetsof the new antineoplastic lanthanum compound KP772 (FFC24). Biochem Pharmacol, 2007, 73(12): 1873―1886

doi: 10.1016/j.bcp.2007.03.002
Ji Y J, Xiao B, Wang Z H, Cui M Z, Lu Y Y. The suppression effect of light rareearth elements on proliferation of two cancer cell lines. Biomed Environ Sci, 2000, 13(4): 287―292
Sato T, Hashizume M, Hotta Y, Okahata Y. Morphologyand proliferation of B16 melanoma cells in the presence of lanthanoidand Al3+ ions. Biometals, 1998, 11(2): 107―112

doi: 10.1023/A:1009273827598
Birchmeier C, Birchmeier W, Gherardi E, Vande Woude G F. Met, metastasis, motility and more. NatRev Mol Cell Biol, 2003, 4(12): 915―925

doi: 10.1038/nrm1261
Trusolino L, Bertotti A, Comoglio P M. A signaling adapter function for a6b4 integrin in thecontrol of HGF-dependent invasive growth. Cell, 2001, 107(5): 643―654

doi: 10.1016/S0092-8674(01)00567-0
Christensen J G, Burrows J, Salgia R. c-Met as a target for human cancer and characterizationof inhibitors for therapeutic intervention. Cancer Lett, 2005, 225(1): 1―26

doi: 10.1016/j.canlet.2004.09.044
Cui J J. Inhibitors targeting hepatocyte growth factor receptor and theirpotential therapeutic applications. ExpertOpin Ther Patents, 2007, 17(9): 1035―1045

doi: 10.1517/13543776.17.9.1035
Comoglio P M, Giordano S, Trusolino L. Drug development of MET inhibitors: targeting oncogeneaddiction and expedience. Nat Rev DrugDiscov, 2008, 7(6): 504―516

doi: 10.1038/nrd2530
Xiao B, Ji Y, Cui M. Effects of lanthanum and cerium on malignant proliferationand expression of tumor-related gene. ZhonghuaYu Fang Yi Xue Za Zhi, 1997, 31(4): 228―230 (in Chinese)
de Freitas D, Donne R L, Hutchison A J. Lanthanum carbonate--a first line phosphate binder? Semin Dial, 2007, 20(4): 325―328

doi: 10.1111/j.1525-139X.2007.00301.x
Li J, Hu G W, Ouyang D, RuiFang N, Yongqia Z, Panwen S. Effect of cerium on expression and activity of MMP-9from human carcinoma of bladder cell line. J Rare Earths (Engl), 2004, 22(2): 288―291
Zhang Y W, Su Y, Volpert O V, Vande Woude G F. Hepatocyte growth factor/scatter factor mediates angiogenesis throughpositive VEGF and negative thrombospondin 1 regulation. Proc Natl Acad Sci U S A, 2003, 100(22): 12718―12723

doi: 10.1073/pnas.2135113100
Peruzzi B, Bottaro D P. Targeting the c-met signalingpathway in cancer. Clin Cancer Res, 2006, 12(12): 3657―3660

doi: 10.1158/1078-0432.CCR-06-0818
Jiang W G, Grimshaw D, Martin T A, Davies G, Parr C, Watkins G, Lane J, Abounader R, Laterra J, Mansel R E. Reduction of stromal fibroblast-inducedmammary tumor growth, by retroviral ribozyme transgenes to hepatocytegrowth factor/scatter factorand its receptor, c-MET. Clin Cancer Res, 2003, 9(11): 4274―4281
You W K, McDonald D M. The hepatocyte growth factor/c-Metsignaling pathway as a therapeutic target to inhibit angiogenesis. BMB Rep, 2008, 41(12): 833―839
Zhou H Y, Pon Y L, Wong A S. HGF/MET signaling in ovarian cancer. Curr Mol Med, 2008, 8(6): 469―480

doi: 10.2174/156652408785747933
Maulik G, Shrikhande A, Kijima T, Ma P C, Morrison P T, Salgia R. Role of the hepatocyte growth factor receptor, c-Met,in oncogenesis and potential for therapeutic inhibition. Cytokine Growth Factor Rev, 2002, 13(1): 41―59

doi: 10.1016/S1359-6101(01)00029-6
[1] Lan Wang,Jueheng Wu,Jie Yuan,Xun Zhu,Hongmei Wu,Mengfeng Li. Midline2 is overexpressed and a prognostic indicator in human breast cancer and promotes breast cancer cell proliferation in vitro and in vivo[J]. Front. Med., 2016, 10(1): 41-51.
[2] Yinyin Xie,Yuanliang Zhang,Lu Jiang,Mengmeng Zhang,Zhiwei Chen,Dan Liu,Qiuhua Huang. Disabled homolog 2 is required for migration and invasion of prostate cancer cells[J]. Front. Med., 2015, 9(3): 312-321.
[3] Runlin Shi,Haibing Xiao,Tao Yang,Lei Chang,Yuanfeng Tian,Bolin Wu,Hua Xu. Effects of miR-200c on the migration and invasion abilities of human prostate cancer Du145 cells and the corresponding mechanism[J]. Front. Med., 2014, 8(4): 456-463.
[4] Kai Qu, Chang Liu, Aasef M A Mansoor, Bo Wang, Jincai Chen, Liang Yu, Yi Lv. Pyogenic liver abscess as initial presentation in locally advanced right colon cancer invading the liver, gallbladder, and duodenum[J]. Front Med, 2011, 5(4): 434-437.
[5] Xiaowei GONG MD, PhD, Xiaoyan MING MD, Xu WANG MM, Daan WANG MD, Peng DENG MM, Yong JIANG MD, PhD, Aihua LIU MD, PhD, . Effect of PRAK gene knockout on the proliferation of mouse embryonic fibroblasts[J]. Front. Med., 2009, 3(4): 379-383.
[6] Bin YANG MS , Xianglin YUAN , Yanmei ZOU , Qingsong XI , Guoxian LONG , Qiang FU , Guangyuan HU MM , . Effects of hypoxia inducible factor-1alpha siRNA on the invasion of human Hela cells and expression of related proteins[J]. Front. Med., 2009, 3(3): 303-308.
[7] Gang WANG. NADPH oxidase and reactive oxygen species as signaling molecules in carcinogenesis[J]. Front Med Chin, 2009, 3(1): 1-7.
[8] ZHAN Rong, YU Qinghong, HUANG Haobo. Effect of arsenic trioxide on proliferation and apoptosis of U266 cells and its relationship with the expression variation of VEGF[J]. Front. Med., 2008, 2(4): 356-360.
[9] ZHANG Shilong, ZENG Fuqing, PENG Shibo, WANG Liang. Effect on proliferation and apoptosis of T24 cell lines via silencing DNMT1 with RNA interference[J]. Front. Med., 2008, 2(4): 374-379.
[10] JIN Qiumei, LI Yan, SUN Zengrong. Estrogenic activities of di-2-ethylhexyl phthalate[J]. Front. Med., 2008, 2(3): 303-308.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed